Natera, Inc. (NTRA) bonds
NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30138% above fair value
$287.47−1.01 (-0.35%)
Close on Nov 17, 2026Market cap $41.44BP/E –Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Natera reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
As tagged in Natera's 10-Q for the period ended Jun 30, 2026
Natera's filings do not break debt down by note
The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size | Available | Drawn |
|---|---|---|---|
| Line Of Credit-UBS | $100.00M | $20.00M | – |
| UBS Credit Line | $100.00M | $20.00M | $80.30M |
See a number that looks wrong?